Lilium Tigrinum
NDC 37662-1764, Lilium Tigrinum, pellet, from Hahnemann Laboratories, INC..
- Product NDC
- 37662-1764
- Status
- Listed
- Labeler
- Hahnemann Laboratories, INC.
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/37662-1764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LILIUM LANCIFOLIUM WHOLE FLOWERING500 [hp_C]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 37662-1764-1 | 37662176401 | 200 PELLET in 1 VIAL, GLASS (37662-1764-1) |
| 37662-1764-2 | 37662176402 | 500 PELLET in 1 VIAL, GLASS (37662-1764-2) |
| 37662-1764-3 | 37662176403 | 3000 PELLET in 1 BOTTLE, GLASS (37662-1764-3) |
| 37662-1764-4 | 37662176404 | 10000 PELLET in 1 BOTTLE, GLASS (37662-1764-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 37662-1764 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/37662-1764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 37662-1764. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.